Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (Rituximab)
Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (Rituximab)
We describe a 54-year-old man with resistant pemphigus vulgaris. Standard therapies had afforded inadequate control and have been associated with considerable side-effects. The anti-CD20 monoclonal antibody, Rituximab (MabThera, Roche), was trialled with significant benefit. We discuss its potential mechanism of action.
366-368
Cooper, H.L.
80852309-f99f-4024-a4d7-71ba0342261a
Healy, E.
400fc04d-f81a-474a-ae25-7ff894be0ebd
Theaker, J.M.
e24ec934-c79c-471c-8556-d38a15ac845b
Friedmann, P.S.
d50bac23-f3ec-4493-8fa0-fa126cbeba88
July 2003
Cooper, H.L.
80852309-f99f-4024-a4d7-71ba0342261a
Healy, E.
400fc04d-f81a-474a-ae25-7ff894be0ebd
Theaker, J.M.
e24ec934-c79c-471c-8556-d38a15ac845b
Friedmann, P.S.
d50bac23-f3ec-4493-8fa0-fa126cbeba88
Cooper, H.L., Healy, E., Theaker, J.M. and Friedmann, P.S.
(2003)
Treatment of resistant pemphigus vulgaris with an anti-CD20 monoclonal antibody (Rituximab).
Clinical and Experimental Dermatology, 28 (4), .
(doi:10.1046/j.1365-2230.2003.01283.x).
Abstract
We describe a 54-year-old man with resistant pemphigus vulgaris. Standard therapies had afforded inadequate control and have been associated with considerable side-effects. The anti-CD20 monoclonal antibody, Rituximab (MabThera, Roche), was trialled with significant benefit. We discuss its potential mechanism of action.
This record has no associated files available for download.
More information
Published date: July 2003
Identifiers
Local EPrints ID: 27003
URI: http://eprints.soton.ac.uk/id/eprint/27003
ISSN: 0307-6938
PURE UUID: cf492800-318f-407d-ba2f-3ffc8e2210e6
Catalogue record
Date deposited: 26 Apr 2006
Last modified: 15 Mar 2024 07:14
Export record
Altmetrics
Contributors
Author:
H.L. Cooper
Author:
J.M. Theaker
Author:
P.S. Friedmann
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics